Description:
Antimicrobial resistance (AMR) is a serious global threat. To combat potential epidemic, requires both industry and government collaboration on an international level in antibiotic R&D investment, preventive measures and emergency response. Expanding horizons on the growing global threat of AMR for almost two decades, Superbugs & Superdrug’s will once again play host to an international audience of anti-infective experts, providing a focal point to discuss the latest clinical advancements and funding opportunities. The agenda for 2016 includes compelling talks from European Commission, BARDA, Centre for Anti-Infective Agents, Cempra Pharmaceuticals, Spero Therapeutics, Public Health England, Chemical Biology Ventures, plus many more!

Website

Organizer:
SMi Group Ltd
2 Floor Harling House 47-51 Great Suffolk Street
LONDON, ENGLAND SE1 0BS
United Kingdom

Phone +44 207 827 60 00
tarri[at]smi-online.co.uk